Fonte: Biology of Blood and Marrow Transplantation. Unidade: FCF
Assuntos: TRANSPLANTE DE MEDULA ÓSSEA, NANOPARTÍCULAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROHR, Sandra Serson et al. Novel approach for bone marrow transplantation conditioning in acute myelogenous Leukemia not responding to the induction therapy using etoposide carried in lipid core nanoparticles: a pilot clinical study. Biology of Blood and Marrow Transplantation, v. 26, n. 11, p. 2027-2033, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.010. Acesso em: 11 out. 2024.APA
Rohr, S. S., Maranhão, R. C., Tavoni, T. M., Morikawa, A. T., Areco, K., Deus, D. F., & Oliveira, J. R. (2020). Novel approach for bone marrow transplantation conditioning in acute myelogenous Leukemia not responding to the induction therapy using etoposide carried in lipid core nanoparticles: a pilot clinical study. Biology of Blood and Marrow Transplantation, 26( 11), 2027-2033. doi:10.1016/j.bbmt.2020.07.010NLM
Rohr SS, Maranhão RC, Tavoni TM, Morikawa AT, Areco K, Deus DF, Oliveira JR. Novel approach for bone marrow transplantation conditioning in acute myelogenous Leukemia not responding to the induction therapy using etoposide carried in lipid core nanoparticles: a pilot clinical study [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2027-2033.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.010Vancouver
Rohr SS, Maranhão RC, Tavoni TM, Morikawa AT, Areco K, Deus DF, Oliveira JR. Novel approach for bone marrow transplantation conditioning in acute myelogenous Leukemia not responding to the induction therapy using etoposide carried in lipid core nanoparticles: a pilot clinical study [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2027-2033.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.010